Abstract:AIM To develop high performance liquid chromatography(HPLC) methods for the determination of telmisartan and hydrochlorothiazide in human plasma,which were utilized to study the pharmacokinetics of telmisartan compound tablet in 12 healthy male volunteers.METHODS A single oral dose compound tablet was given to each volunteer according to an open,single-center study.The telmisartan and hydrochlorothiazide concentrations in plasma were determined by HPLC-fluorescence and LC-MS/MS(tandem mass sepctrometry) method respectively.AUC was calculated by trapezoidal rule.The measured value of t_(max) andρ_(max) was used as the final one,and the other main pharmacokinetic parameters were caculated by program DAS 2.0.RESULTS The calibration curve of telmisartan was linear in the range of 2.5-500μg·L~(-1)(r=0.999 9).The detection of limit(LOD) was calculated to be 1.25μg·L~(-1).The recovery of telmisartan was demonstrated to be 99.42%-108.69%,with RSD lower than 2.62%.As for hydrochlorothiazide,a good linear correlation was obtained in the range of 1-500μg·L~(-1)(r=0.999 4) with the LOD of 0.5μg·L~(-1).And the recovery of hydrochlorothiazide was demonstrated to be 95.58%-112.15%,with RSD lower than 4.86%.The main pharmacokinetic parameters of telmisartan in 12 volunteers were as follows:AUC_(0→t),was(1800±859)μg·L~(-1); AUC_(0→∞) was(1967±858)μg·h·L~(-1);ρ_(max) was(181±68)μg·L~(-1);t_(max) was(1.7±0.9) h;t_(1/2) was(22.15±10.64) h.The phannacokinetic parameters of hydrochlorothiazide were as follows:AUC_(0→t) was(519±151)μg·h·L~(-1); AUC_(0→∞) was(542±149)μg·h·L~(-1);ρ_(max) was(72.3±25.1)μg·L~(-1);t_(max) was(2.3±0.9) h;t_(1/2) was(7.44±2.50) h.CONCLUSION The established methods are sensitive,accurate,specific,and suitable for the determination of two components in human plasma after a single oral dose of compound tablet.The main pharmacokinetic parameters of telmisartan and hydrochlorothiazide have no significant differences from the data offered by the references.It is demonstrated that there is no cross-talk on drug effect in vivo between these two components.

Pharmacokinetic Characteristics of Telmisartan in Chinese Healthy Volunteers

Study on Pharmacokinetics of Compound Telmisartan Tablets in Chinese Healthy Volunteers

Pharmacokinetics of Compound Telmisartan Tablets in Chinese Healthy Volunteers

Pharmacokinetics and bioequivalence of telmisartan in Chinese healthy volunteers

Influence of Administering Food on Pharmacokinetics of Telmisartan Tablet in Healthy Subjects

[A Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 80 Mg in Chinese Hypertensive Patients Who Failed to Respond Adequately to Telmisartan 80 Mg].

Pharmacokinetics of Hydrochlorothiazide After Received Tested Compound Telmisartan Tablets in Healthy Volunteers

Pharmacokinetics and Safety of Pitavastatin Calcium Tablets in Chinese Healthy Volunteers after a Single Oral Dose Administration

Study of Pharmacokinetics and Bioequivalence of Telmisartan in Human Plasma by HPLC-MS Method

Pharmacokinetics and Bioequivalence of Telmisartan Tablets and Capsules

Research on Bioequivalence of Telmisartan Tablets in Healthy Volunteers

Determination of two components in telmisartan compound tablet in human plasma and its pharmacokinetic characteristics

Pharmacokinetics of Compound Olmesartan Medoxomil and Hydrochlorothiazide Tablets in Chinese Healthy Volunteers

Determination of telmisartan in human plasma by HPLC mass spectrometry and studies on its pharmacokinetics and relative bioavailability

Effects of Genetic Variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of Telmisartan in Chinese Patients with Mild to Moderate Essential Hypertension

Polymorphism Of Orm1 Is Associated With The Pharmacokinetics Of Telmisartan

No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.

Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis

The Influence of Telmisartan on Metformin Pharmacokinetics and Pharmacodynamics.

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetic-pharmacodynamic Modeling of Telmisartan Using an Indirect Response Model in Spontaneously Hypertensive Rats